ARTERIAL HYPERTENSION: WHEN AN UNUSUAL CAUSE ARISES
DOI:
https://doi.org/10.58043/rphrc.103Keywords:
arterial hypertension, Cushing syndrome, suprarenal carcinoma, cardiovascular riskAbstract
Arterial hypertension (AHT) is the main risk factor to the cardiovascular disease. It can be classified as primary or secondary. The endocrine causes, such as the Cushing syndrome (CS), represent a source of secondary AHT and should be investigated when facing disease stigmas.
The CS is provoked by the increase of the serum cortisol and is considered an unusual cause of AHT. The arteriosclerosis and the cardiac remodeling associated to AHT significantly increase the mortality by cardiovascular causes (CV) and the people who suffer from these conditions have a higher CV risk when compared to the general population.
The following case depicts a AHT situation provoked again by endocrine causes, particularly by adrenal carcinoma.
Downloads
References
Charles L. et al, Secondary Hypertension: Discovering the Underlying Cause, American Family Physician 2017; 96:7;
Rossi G. et al, Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension, High Blood Pressure & Cardiovascular Prevention (2020) 27:547–560;
Barbot M. et al, Best Practice Research Clinical Endocrinology & Metabolism: Cushing’s syndrome: Overview of clinical presentation, diagnostic tools and complications 34 2020; 101380;
Nieman L., Diagnosis of Cushing’s Syndrome in the Modern Era, Endocrinol Metab Clin N Am 47 2018; 259– 273;
Cingolani O., Cardiovascular Risks and Organ Damage in Secondary Hypertension, Endocrinol Metab Clin N Am 48 2019; 657–666;
Pivonello R., Martino M. et al, Cushing’s disease: the burden of illness, Endocrine 2017 56:10–18;
Webb S., Valassi E., Morbidity of Cushing Syndrome and Impact of Treatment, Endocrinol Metab Clin North Am. 2018 Jun;47(2):299-311;
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Liliana Sousa
This work is licensed under a Creative Commons Attribution 4.0 International License.
